Skip to content

C84.A8 ICD-10-CM Code: Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites

C84.A8 maps to CMS-HCC V28 20. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC Buddy coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC84.A8

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

C84.A8

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites

A type of blood cancer affecting T-cells in the skin that has spread to lymph nodes in multiple locations throughout the body.

Buddy the Bee presenting code insight

Buddy Insight

Cutaneous T-cell lymphoma involving multiple lymph node regions indicates advanced disseminated disease with poor prognosis.

CMS-HCC V28

HCC 20

Coefficient HCC 20: 1.136 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 010

Code-level coefficient reference

ESRD/PACE

HCC 10

Code-level coefficient reference

RXHCC

HCC 21

Code-level coefficient reference

Inclusion Terms

Official

No inclusion terms are included in this display for C84.A8. Check the code and parent instructions in the Code Book.

Excludes 2

Official
  • Kaposi's sarcoma of lymph nodes (C46.3)Inherited from C81-C96
  • secondary and unspecified neoplasm of lymph nodes (C77.-)Inherited from C81-C96
  • secondary neoplasm of bone marrow (C79.52)Inherited from C81-C96
  • secondary neoplasm of spleen (C78.89)Inherited from C81-C96

Includes

Official

No Includes notes are included in this display for C84.A8. Check the code and parent instructions in the Code Book.

Excludes 1

Official
  • personal history of non-Hodgkin lymphoma (Z85.72)Inherited from C84

Code First

Official

No Code First sequencing instructions are included in this display for C84.A8. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for C84.A8. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for C84.A8. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Documentation must specify involvement of lymph nodes in at least two distinct anatomical regions
Pathology confirmation of cutaneous T-cell lymphoma subtype via skin biopsy with immunophenotyping
Imaging (CT, PET) confirming multi-site lymph node enlargement consistent with lymphomatous involvement
Clinical staging reflecting extent of nodal disease

MEAT Support

HCC Buddy guidance
Documentation must specify involvement of lymph nodes in at least two distinct anatomical regions
Pathology confirmation of cutaneous T-cell lymphoma subtype via skin biopsy with immunophenotyping
Imaging (CT, PET) confirming multi-site lymph node enlargement consistent with lymphomatous involvement
Clinical staging reflecting extent of nodal disease

Audit Caution

HCC Buddy guidance
Using C84.A8 when only one lymph node region is involved — single-site involvement requires a site-specific code
Failing to distinguish between reactive lymphadenopathy and lymphomatous involvement
Not querying when documentation mentions 'lymphadenopathy' without specifying if it is lymphoma-related
Defaulting to unspecified site when imaging clearly shows multi-site nodal disease

Common Mistakes

HCC Buddy guidance
C84.A0 (Cutaneous T-cell lymphoma, unspecified site) — Use C84.A8 when multiple lymph node regions are specifically documented
C84.A1 through C84.A6 (site-specific codes) — Use these when only a single nodal region is involved; C84.A8 requires multiple regions
C84.A9 (Cutaneous T-cell lymphoma, extranodal/solid organ sites) — C84.A8 is for nodal disease; C84.A9 is for disease outside lymph nodes

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C84.A8 an HCC code?

Yes. C84.A8 (Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites) maps to HCC 20, Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 1.136. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: C84.A8 is billable and maps to V28 HCC 20, Lung and Other Severe Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C84.A8
Description
Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites
HCC (V28)
HCC 20 — Lung and Other Severe Cancers
RAF reference coefficient
1.136
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 20, Lung and Other Severe Cancers
1.136
ESRDHCC 10, Lymphoma and Other Cancers
Not separately weighted
RxHCCHCC 21, Lymphomas and Other Hematologic Cancers
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work C84.A8 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for C84.A8

For C84.A8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C84.A8 is the ICD-10-CM diagnosis code for cutaneous t-cell lymphoma, unspecified, lymph nodes of multiple sites. A type of blood cancer affecting T-cells in the skin that has spread to lymph nodes in multiple locations throughout the body. C84.A8 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).

Under the CMS-HCC V28 risk adjustment model, C84.A8 maps to Lung and Other Severe Cancers (HCC 20) with a source-labeled community, non-dual, aged reference coefficient of 1.136. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

This code is used when cutaneous T-cell lymphoma involves multiple lymph node regions; verify documentation specifies multiple sites rather than a single site. For C84.A8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C84.A8 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • This code is used when cutaneous T-cell lymphoma involves multiple lymph node regions; verify documentation specifies multiple sites rather than a single site
  • Ensure the primary site is documented as cutaneous (skin) with secondary involvement of lymph nodes

Clinical Significance

Cutaneous T-cell lymphoma involving multiple lymph node regions indicates advanced disseminated disease with poor prognosis. Multi-site nodal involvement typically corresponds to stage III-IV disease requiring aggressive systemic treatment. This code captures the extent of lymphomatous spread essential for accurate risk stratification.

Documentation Requirements

  • Documentation must specify involvement of lymph nodes in at least two distinct anatomical regions
  • Pathology confirmation of cutaneous T-cell lymphoma subtype via skin biopsy with immunophenotyping
  • Imaging (CT, PET) confirming multi-site lymph node enlargement consistent with lymphomatous involvement
  • Clinical staging reflecting extent of nodal disease

Commonly Confused Codes

  • C84.A0 (Cutaneous T-cell lymphoma, unspecified site): Use C84.A8 when multiple lymph node regions are specifically documented
  • C84.A1 through C84.A6 (site-specific codes): Use these when only a single nodal region is involved; C84.A8 requires multiple regions
  • C84.A9 (Cutaneous T-cell lymphoma, extranodal/solid organ sites): C84.A8 is for nodal disease; C84.A9 is for disease outside lymph nodes

Child Codes

Code Hierarchy

Also searched as

  • C84 A8
  • C84A8

For C84.A8, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

C84.A8 maps to CMS-HCC V28 category 20, Lung and Other Severe Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for C84.A8. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work C84.A8 in HCC Buddy

Open C84.A8 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.